Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIX) through any online brokerage.
Other companies in Protagenic Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Trevena (NASDAQ:TRVN).
Protagenic Therapeutics has a consensus price target of $4.00.
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $0.5994 last updated September 24, 2024 at 6:02 PM EDT.
There are no upcoming dividends for Protagenic Therapeutics.
Protagenic Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Protagenic Therapeutics.
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.